Regulation of SETD2 maintains immune regulatory function in macrophages to suppress airway allergy.
Lei ZhangJunyi WangXiaoyu LiuXiaojun XiaoYu LiuQinmiao HuangJing LiGuoping LiPing-Chang YangPublished in: Immunology (2024)
SET domain-containing 2 (SETD2) is a histone methyltransferase. It regulates the activity of H3K36me3 to enhance gene transcription. Macrophages (Mϕs) are one of the cell types involved in immune response. The purpose of this study is to clarify the role of SETD2 in regulating the immune property of Mϕ. The Mφs were isolated from the bronchoalveolar lavage fluid (BALF) and analysed through flow cytometry and RNA sequencing. A mouse strain carrying Mφs deficient in SETD2 was used. A mouse model of airway allergy was established with the ovalbumin/alum protocol. Less expression of SETD2 was observed in airway Mϕs in patients with allergic asthma. SETD2 of M2 cells was associated with the asthmatic clinical response. Sensitization reduced the expression of SETD2 in mouse respiratory tract M2 cells, which is associated with the allergic reaction. Depletion of SETD2 in Mφs resulted in Th2 pattern inflammation in the lungs. SETD2 maintained the immune regulatory ability in airway M2 cells. SETD2 plays an important role in the maintenance of immune regulatory property of airway Mφs.
Keyphrases
- induced apoptosis
- immune response
- mouse model
- cell cycle arrest
- poor prognosis
- flow cytometry
- transcription factor
- respiratory tract
- single cell
- oxidative stress
- randomized controlled trial
- gene expression
- chronic obstructive pulmonary disease
- lung function
- stem cells
- allergic rhinitis
- genome wide
- copy number
- mesenchymal stem cells
- bone marrow
- binding protein
- cell therapy